A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin

BACKGROUND: To assess the effect of fidaxomicin and vancomycin on Clostridium difficile toxins and correlation with clinical and microbiologic outcomes. METHODS: Hospitalized patients with C. difficile infection were randomly assigned a 10-day course of fidaxomicin or vancomycin. Stool samples colle...

Descripción completa

Detalles Bibliográficos
Autores principales: Thabit, Abrar K., Alam, M. Jahangir, Khaleduzzaman, Mohammed, Garey, Kevin W., Nicolau, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830079/
https://www.ncbi.nlm.nih.gov/pubmed/27071986
http://dx.doi.org/10.1186/s12941-016-0140-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830079/
https://www.ncbi.nlm.nih.gov/pubmed/27071986
http://dx.doi.org/10.1186/s12941-016-0140-6

Ejemplares similares